|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2006-10-2
|
|
pubmed:abstractText |
The objective of this study was to evaluate dynamic contrast-enhanced Doppler ultrasound (DCE-US) with perfusion software (Vascular Recognition Imaging) and contrast agent injection as a predictor of tumour response, progression-free survival (PFS) and overall survival (OS).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0959-8049
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2472-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16965911-Adult,
pubmed-meshheading:16965911-Antineoplastic Agents,
pubmed-meshheading:16965911-Benzenesulfonates,
pubmed-meshheading:16965911-Carcinoma, Renal Cell,
pubmed-meshheading:16965911-Contrast Media,
pubmed-meshheading:16965911-Disease Progression,
pubmed-meshheading:16965911-Disease-Free Survival,
pubmed-meshheading:16965911-Double-Blind Method,
pubmed-meshheading:16965911-Female,
pubmed-meshheading:16965911-Humans,
pubmed-meshheading:16965911-Kidney Neoplasms,
pubmed-meshheading:16965911-Male,
pubmed-meshheading:16965911-Middle Aged,
pubmed-meshheading:16965911-Phospholipids,
pubmed-meshheading:16965911-Pilot Projects,
pubmed-meshheading:16965911-Pyridines,
pubmed-meshheading:16965911-Randomized Controlled Trials as Topic,
pubmed-meshheading:16965911-Sulfur Hexafluoride,
pubmed-meshheading:16965911-Survival Analysis,
pubmed-meshheading:16965911-Treatment Outcome,
pubmed-meshheading:16965911-Ultrasonography, Doppler
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound.
|
|
pubmed:affiliation |
Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
